Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
Sign Up to like & getrecommendations! Published in 2017 at "PLoS Medicine"
DOI: 10.1371/journal.pmed.1002190
Abstract: Aaron Kesselheim and colleagues examine orphan-designated drugs approved between 2009 and 2015 in the United States. read more here.
Keywords: diseases policy; biomarker defined; common diseases; defined subsets ... See more keywords